By M T
In episode 3 of Behind the Batch, our host Alex Shephard chats with Jay Rosanelli, Co-Founder and CEO of Syenex. He discusses his move from neuropharmacology research into investment banking and then into founding a biotech built around targeted delivery technologies for genetic medicines, covering the technical failures along the way, the realities of raising … Continued
By M T
In this presentation from BioProcess International 2026, Alex Shephard, Tozaro’s Head of Product, explores how Smart Polymer™ technology can address some of the key challenges in viral vector downstream processing. Discover how Tozaro’s computationally designed synthetic affinity ligands offer a new approach to purification, combining target specificity and tunable binding affinity with the potential for … Continued
By M T
Abdullah Sufan, Head of CGT Applications at Tozaro presented ‘A new approach to designing synthetic affinity ligands for enhanced viral vector analytics and purification’ at Bioprocess International 2024. In this 25-minute recording you can hear: Watch now
By M T
In this presentation at Cell and Gene Meeting on the MESA 2025, Tozaro’s CEO Jason Slingsby provided an update on the adoption of Smart PolymersTM in viral vector purification. Tune in for the next 15 minutes to learn: Watch now:
By M T
Jason Slingsby, CEO at Tozaro presents at Cell and Gene Meeting on the Med 2026. Watch this 15 minute presentation for an update on how Tozaro’s Smart PolymerTM Platform Technology is being used to design new affinity ligands for the purification of viral vectors. What you will learn: Watch now:
By M T
Behind the Batch spotlights the moments that shape the people pioneering cell and gene therapy. Failed batches, first viable runs, tech transfers, and everything in between. In episode 2, our host Alex Shephard chats with Giuliana Vallanti, SVP Operations and R&D at AGC Biologics. She discusses two decades in cell and gene therapy, from process … Continued
By M T
Behind the Batch spotlights the moments that shape the people pioneering cell and gene therapy. Failed batches, first viable runs, tech transfers, and everything in between. In episode 1, our host Alex Shephard chats with Andre Raposo, Senior Director of Innovation about his journey from fundamental HIV research to leading innovation in viral vector manufacturing … Continued